Securities code: 603858 securities abbreviation: Shandong Buchang Pharmaceuticals Co.Ltd(603858) Announcement No.: 2022-002 Shandong Buchang Pharmaceuticals Co.Ltd(603858)
Supplementary announcement on the listing license of Xuanfei Baidu granules in Canada
The company and all members of the board of directors guarantee that there are no false records, misleading statements or major omissions in the contents of the announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of the contents.
Xianyang step Trading Development Co., Ltd. (formerly known as Xianyang step Medicine Co., Ltd.), a wholly-owned subsidiary of Shandong Buchang Pharmaceuticals Co.Ltd(603858) (hereinafter referred to as “the company”), recently received a product license for “natural health products” approved and issued by the Canadian Ministry of health. The company’s product Xuanfei septic granules meet the Canadian natural health product standards and are allowed to be listed and sold according to the natural health product standards, For details, please refer to the announcement on the listing license of Xuanfei Baidu granules in Canada (Announcement No.: 2022-001) disclosed by the company on January 1, 2022. Relevant information is hereby supplemented as follows:
The company’s product Xuanfei Baidu granule meets the Canadian natural health product standard and is allowed to be listed and sold in Canada as natural health products.
It is hereby announced.
Shandong Buchang Pharmaceuticals Co.Ltd(603858) board of directors January 1, 2022
